A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL

DSpace Repository

A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL

Author: Staiger, Annette M.; Altenbuchinger, Michael; Ziepert, Marita; Kohler, Christian; Horn, Heike; Huttner, Michael; Huettl, Katrin S.; Glehr, Gunther; Klapper, Wolfram; Szczepanowski, Monika; Richter, Julia; Stein, Harald; Feller, Alfred C.; Moeller, Peter; Hansmann, Martin-Leo; Poeschel, Viola; Held, Gerhard; Loeffler, Markus; Schmitz, Norbert; Truemper, Lorenz; Pukrop, Tobias; Rosenwald, Andreas; Ott, German; Spang, Rainer; Siebert, Reiner; Pfreundschuh, Michael
Tübinger Autor(en):
Staiger, Annette M.
Horn, Heike
Published in: Leukemia (2020), Bd. 34, H. 2, S. 543-552
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/s41375-019-0573-y
ISSN: 1476-5551
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)